Misplaced Pages

Bell's palsy
A person attempting to show his teeth and raise his eyebrows with Bell's palsy on his right side. Note how the forehead is not spared.
Specialty	Neurology, Ophthalmology, ENT, oral and maxillofacial surgery
Symptoms	Inability to move the facial muscles on one side, change in taste, pain around the ear
Usual onset	Over 48 hours
Duration	< 6 months
Causes	Unknown
Risk factors	Diabetes, recent upper respiratory tract infection
Diagnostic method	Based on symptoms
Differential diagnosis	Brain tumor, stroke, Ramsay Hunt syndrome type 2, Lyme disease
Treatment	Corticosteroids, eye drops, eyepatch
Prognosis	Most recover completely
Frequency	1–4 per 10,000 per year

Bell's palsy is a type of facial paralysis that results in a temporary inability to control the facial muscles on the affected side of the face. In most cases, the weakness is temporary and significantly improves over weeks. Symptoms can vary from mild to severe. They may include muscle twitching, weakness, or total loss of the ability to move one or, in rare cases, both sides of the face. Other symptoms include drooping of the eyebrow, a change in taste, and pain around the ear. Typically symptoms come on over 48 hours. Bell's palsy can trigger an increased sensitivity to sound known as hyperacusis.

The cause of Bell's palsy is unknown and it can occur at any age. Risk factors include diabetes, a recent upper respiratory tract infection, and pregnancy. It results from a dysfunction of cranial nerve VII (the facial nerve). Many believe that this is due to a viral infection that results in swelling. Diagnosis is based on a person's appearance and ruling out other possible causes. Other conditions that can cause facial weakness include brain tumor, stroke, Ramsay Hunt syndrome type 2, myasthenia gravis, and Lyme disease.

The condition normally gets better by itself, with most achieving normal or near-normal function. Corticosteroids have been found to improve outcomes, while antiviral medications may be of a small additional benefit. The eye should be protected from drying up with the use of eye drops or an eyepatch. Surgery is generally not recommended. Often signs of improvement begin within 14 days, with complete recovery within six months. A few may not recover completely or have a recurrence of symptoms.

Bell's palsy is the most common cause of one-sided facial nerve paralysis (70%). It occurs in 1 to 4 per 10,000 people per year. About 1.5% of people are affected at some point in their lives. It most commonly occurs in people between ages 15 and 60. Males and females are affected equally. It is named after Scottish surgeon Charles Bell (1774–1842), who first described the connection of the facial nerve to the condition.

Although defined as a mononeuritis (involving only one nerve), people diagnosed with Bell's palsy may have "myriad neurological symptoms", including "facial tingling, moderate or severe headache/neck pain, memory problems, balance problems, ipsilateral limb paresthesias, ipsilateral limb weakness, and a sense of clumsiness" that are "unexplained by facial nerve dysfunction".

Signs and symptoms

Bell's palsy is characterized by a one-sided facial droop that comes on within 72 hours. In rare cases (<1%), it can occur on both sides resulting in total facial paralysis.

The facial nerve controls many functions, such as blinking and closing the eyes, smiling, frowning, lacrimation, salivation, flaring nostrils and raising eyebrows. It also carries taste sensations from the anterior two-thirds of the tongue, through the chorda tympani nerve (a branch of the facial nerve). Because of this, people with Bell's palsy may present with loss of taste sensation in the anterior 2⁄3 of the tongue on the affected side.

Although the facial nerve innervates the stapedius muscle of the middle ear (through the tympanic branch), sound sensitivity, causing normal sounds to be perceived as very loud (hyperacusis), and dysacusis is possible but hardly ever clinically evident.

Cause

The cause of Bell's palsy is unknown. Risk factors include diabetes, a recent upper respiratory tract infection, and pregnancy.

Some viruses are thought to establish a persistent (or latent) infection without symptoms, e.g., the varicella zoster virus and the Epstein–Barr virus, both of the herpes family. Reactivation of an existing (dormant) viral infection has been suggested as a cause of acute Bell's palsy. As the facial nerve swells and becomes inflamed in reaction to the infection, it causes pressure within the Fallopian canal, resulting in the restriction of blood and oxygen to the nerve cells. Other viruses and bacteria that have been linked to the development of Bell's palsy include HIV, sarcoidosis and Lyme disease. This new activation could be triggered by trauma, environmental factors, and metabolic or emotional disorders.

Familial inheritance has been found in 4–14% of cases. There may also be an association with migraines.

In December 2020, the U.S. FDA recommended that recipients of the Pfizer and Moderna COVID-19 vaccines should be monitored for symptoms of Bell's palsy after several cases were reported among clinical trial participants, though the data were not sufficient to determine a causal link.

Genetics

A meta-analysis of genome-wide association study (GWAS) identified the first unequivocal association with Bell's palsy.

Pathophysiology

Bell's palsy is the result of a malfunction of the facial nerve (cranial nerve VII), which controls the muscles of the face. Facial palsy is typified by an inability to move the muscles of facial expression. The paralysis is of the infranuclear/lower motor neuron type.

It is thought that as a result of inflammation of the facial nerve, pressure is produced on the nerve where it exits the skull within its bony canal (the stylomastoid foramen), blocking the transmission of neural signals or damaging the nerve. Patients with facial palsy for which an underlying cause can be found are not considered to have Bell's palsy per se. Possible causes of facial paralysis include tumor, meningitis, stroke, diabetes mellitus, head trauma and inflammatory diseases of the cranial nerves (sarcoidosis, brucellosis, etc.). In these conditions, the neurologic findings are rarely restricted to the facial nerve. Babies can be born with facial palsy. In a few cases, bilateral facial palsy has been associated with acute HIV infection.

In some research, the herpes simplex virus type 1 (HSV-1) has been identified in a majority of cases diagnosed as Bell's palsy through endoneurial fluid sampling. Other research, however, identified, out of a total of 176 cases diagnosed as Bell's palsy, HSV-1 in 31 cases (18%) and herpes zoster in 45 cases (26%).

In addition, HSV-1 infection is associated with demyelination of nerves. This nerve damage mechanism is different from the above-mentioned—that edema, swelling, and compression of the nerve in the narrow bone canal are responsible for nerve damage. Demyelination may not even be directly caused by the virus but by an unknown immune response.

Diagnosis

Bell's palsy is a diagnosis of exclusion, meaning it is diagnosed by the elimination of other reasonable possibilities. By definition, no specific cause can be determined. There are no routine lab or imaging tests required to make the diagnosis. The degree of nerve damage can be assessed using the House-Brackmann score.

One study found that 45% of patients are not referred to a specialist, which suggests that Bell's palsy is considered by physicians to be a straightforward diagnosis that is easy to manage.

Other conditions that can cause similar symptoms include herpes zoster, Lyme disease, sarcoidosis, stroke, and brain tumors.

Differential diagnosis

Once the facial paralysis sets in, many people may mistake it as a symptom of a stroke; however, there are a few subtle differences. A stroke will usually cause a few additional symptoms, such as numbness or weakness in the arms and legs. And unlike Bell's palsy, a stroke will usually let patients control the upper part of their faces. A person with a stroke will usually have some wrinkling on their forehead.

In areas where Lyme disease is common, it accounts for about 25% of cases of facial palsy. In the U.S., Lyme is most common in the New England and Mid-Atlantic states and parts of Wisconsin and Minnesota. The first sign of about 80% of Lyme infections, typically one or two weeks after a tick bite, is usually an expanding rash that may be accompanied by headaches, body aches, fatigue, or fever. In up to 10–15% of Lyme infections, facial palsy appears several weeks later, and may be the first sign of infection that is noticed as the Lyme rash typically does not itch and is not painful. The likelihood that the facial palsy is caused by Lyme disease should be estimated, based on the recent history of outdoor activities in likely tick habitats during warmer months, a recent history of rash or symptoms such as headache and fever, and whether the palsy affects both sides of the face (much more common in Lyme than in Bell's palsy). If that likelihood is more than negligible, a serological test for Lyme disease should be performed, and if it exceeds 10%, empiric therapy with antibiotics should be initiated, without corticosteroids, and reevaluated upon completion of laboratory tests for Lyme disease. Corticosteroids have been found to harm outcomes for facial palsy caused by Lyme disease.

One disease that may be difficult to exclude in the differential diagnosis is the involvement of the facial nerve in infections with the herpes zoster virus. The major differences in this condition are the presence of small blisters, or vesicles, on the external ear, significant pain in the jaw, ear, face, and/or neck, and hearing disturbances, but these findings may occasionally be lacking (zoster sine herpete). Reactivation of existing herpes zoster infection leading to facial paralysis in a Bell's palsy type pattern is known as Ramsay Hunt syndrome type 2. The prognosis for Bell's palsy patients is generally much better than for Ramsay Hunt syndrome type 2 patients.

Treatment

Steroids are effective at improving recovery in Bell's palsy while antivirals have not. In those who are unable to close their eyes, eye-protective measures are required. Management during pregnancy is similar to management in the non-pregnant.

Steroids

Corticosteroids such as prednisone improve recovery at 6 months and are thus recommended. Early treatment (within 3 days after the onset) is necessary for benefit with a 14% greater probability of recovery. There is some debate regarding the optimal dosing strategy which is generally physician dependent.

Antivirals

One review found that antivirals (such as aciclovir) are ineffective in improving recovery from Bell's palsy beyond steroids alone in mild to moderate disease. Another review found a benefit when combined with corticosteroids but stated the evidence was not very good to support this conclusion.

In severe disease, it is also unclear. One 2015 review found no effect regardless of severity. Another review found a small benefit when added to steroids.

They are commonly prescribed due to a theoretical link between Bell's palsy and the herpes simplex and varicella zoster virus. There is still the possibility that they might result in a benefit less than 7% as this has not been ruled out.

Eye protection

When Bell's palsy affects the blink reflex and stops the eye from closing completely, frequent use of tear-like eye drops or eye ointments is recommended during the day, and protecting the eyes with patches or taping them shut is recommended for sleep and rest periods.

Physiotherapy

Physiotherapy can be beneficial to some individuals with Bell's palsy as it helps to maintain muscle tone of the affected facial muscles and stimulate the facial nerve. It is important that muscle re-education exercises and soft tissue techniques be implemented before recovery to help prevent permanent contractures of the paralyzed facial muscles. To reduce pain, heat can be applied to the affected side of the face. There is no high-quality evidence to support the role of electrical stimulation for Bell's palsy.

Surgery

Surgery may be able to improve outcomes in facial nerve palsy that has not recovered. A number of different techniques exist. Smile surgery or smile reconstruction is a surgical procedure that may restore the smile for people with facial nerve paralysis. Adverse effects include hearing loss which occurs in 3–15% of people. A Cochrane review (updated in 2021), after reviewing applicable randomized and quasi-randomized controlled trials was unable to determine if early surgery is beneficial or harmful. As of 2007 the American Academy of Neurology did not recommend surgical decompression.

Alternative medicine

The efficacy of acupuncture remains unknown because the available studies are of low quality (poor primary study design or inadequate reporting practices). There is very tentative evidence for hyperbaric oxygen therapy in severe disease.

Prognosis

Most people with Bell's palsy start to regain normal facial function within three weeks—even those who do not receive treatment. In a 1982 study, when no treatment was available, of 1,011 patients, 85% showed first signs of recovery within three weeks after onset. For the other 15%, recovery occurred 3–6 months later.

After a follow-up of at least one year or until restoration, complete recovery had occurred in more than two-thirds (71%) of all patients. Recovery was judged moderate in 12% and poor in only 4% of patients. Another study found that incomplete palsies disappear entirely, nearly always in one month. The patients who regain movement within the first two weeks nearly always remit entirely. When remission does not occur until the third week or later, a significantly greater part of the patients develop sequelae. A third study found a better prognosis for young patients, aged below 10 years old, while the patients over 61 years old presented a worse prognosis.

Major possible complications of the condition are chronic loss of taste (ageusia), chronic facial spasm, facial pain, and corneal infections. Another complication can occur in case of incomplete or erroneous regeneration of the damaged facial nerve. The nerve can be thought of as a bundle of smaller individual nerve connections that branch out to their proper destinations. During regrowth, nerves are generally able to track the original path to the right destination—but some nerves may sidetrack leading to a condition known as synkinesis. For instance, the regrowth of nerves controlling muscles attached to the eye may sidetrack and also regrow connections reaching the muscles of the mouth. In this way, the movement of one also affects the other. For example, when the person closes the eye, the corner of the mouth lifts involuntarily.

Around 9% of people have some sort of ongoing problems after Bell's palsy, typically the synkinesis already discussed, or spasm, contracture, tinnitus, or hearing loss during facial movement or crocodile-tear syndrome. This is also called gustatolacrimal reflex or Bogorad's syndrome and results in shedding tears while eating. This is thought to be due to faulty regeneration of the facial nerve, a branch of which controls the lacrimal and salivary glands. Gustatorial sweating can also occur.

Epidemiology

The number of new cases of Bell's palsy ranges from about one to four cases per 10,000 population per year. The rate increases with age. Bell's palsy affects about 40,000 people in the United States every year. It affects approximately 1 person in 65 during a lifetime.

A range of annual incidence rates have been reported in the literature: 15, 24, and 25–53 (all rates per 100,000 population per year). Bell's palsy is not a reportable disease, and there are no established registries for people with this diagnosis, which complicates precise estimation.

Frequency

About 40,000 people are affected by Bell's Palsy in the United States every year. It can affect anyone of any gender and age, but its incidence seems to be highest in those in the 15- to 45-year-old age group.

History

This section needs additional citations for verification. Please help improve this article by adding citations to reliable sources in this section. Unsourced material may be challenged and removed. (May 2022) (Learn how and when to remove this message)

The Persian physician Muhammad ibn Zakariya al-Razi (865–925) detailed the first known description of peripheral and central facial palsy.

Cornelis Stalpart van der Wiel (1620–1702) in 1683 gave an account of Bell's palsy and credited the Persian physician Ibn Sina (980–1037) for describing this condition before him. James Douglas (1675–1742) and Nicolaus Anton Friedreich [de] (1761–1836) also described it.

Scottish neurophysiologist Sir Charles Bell read his paper to the Royal Society of London on July 12, 1821, describing the role of the facial nerve. He became the first to detail the neuroanatomical basis of facial paralysis. Since then, idiopathic peripheral facial paralysis has been referred to as Bell's palsy, named after him.

A notable person with Bell's palsy is former Prime Minister of Canada Jean Chrétien. During the 1993 Canadian federal election, Chrétien's first as leader of the Liberal Party of Canada, the opposition Progressive Conservative Party of Canada ran an attack ad in which voice actors criticized him over images that seemed to highlight his abnormal facial expressions. The ad was interpreted as an attack on Chrétien's physical appearance and garnered widespread anger among the public, while Chrétien used the ad to make himself more sympathetic to voters. The ad had the adverse effect of increasing Chrétien's lead in the polls and the subsequent backlash clinched the election for the Liberals, which the party won in a landslide.

On April 25, 2024, Joel Hans Embiid of the Philadelphia 76ers scored 50 points in Game 3 of the 76ers' first-round playoff series versus the New York Knicks while suffering from a mild case of Bell's Palsy.

References

1. ^ "Bell's Palsy Fact Sheet". National Institute of Neurological Disorders and Stroke. July 25, 2022. Archived from the original on 8 April 2011. Retrieved October 11, 2022.
2. ^ Fuller G, Morgan C (December 2016). "Bell's palsy syndrome: mimics and chameleons". Practical Neurology. 16 (6): 439–44. doi:10.1136/practneurol-2016-001383. PMID 27034243. S2CID 4480197.
3. ^ Madhok VB, Gagyor I, Daly F, Somasundara D, Sullivan M, Gammie F, Sullivan F (July 2016). "Corticosteroids for Bell's palsy (idiopathic facial paralysis)". The Cochrane Database of Systematic Reviews. 2016 (7): CD001942. doi:10.1002/14651858.CD001942.pub5. PMC 6457861. PMID 27428352.
4. ^ "Bell's palsy - Symptoms and causes". Mayo Clinic. Retrieved 2022-03-22.
5. "Bell's Palsy".
6. Purves D (2012). Neuroscience (5th ed.). Sunderland, Massachusetts: Sinauer. p. 283. ISBN 9780878936953.
7. ^ Hussain A, Nduka C, Moth P, Malhotra R (May 2017). "Bell's facial nerve palsy in pregnancy: a clinical review". Journal of Obstetrics and Gynaecology. 37 (4): 409–15. doi:10.1080/01443615.2016.1256973. PMID 28141956. S2CID 205479752.
8. ^ Gagyor I, Madhok VB, Daly F, Somasundara D, Sullivan M, Gammie F, Sullivan F (November 2015). "Antiviral treatment for Bell's palsy (idiopathic facial paralysis)" (PDF). The Cochrane Database of Systematic Reviews (11): CD001869. doi:10.1002/14651858.CD001869.pub8. PMID 26559436.
9. Dickson G (2014). Primary Care ENT, An Issue of Primary Care: Clinics in Office Practice. Elsevier Health Sciences. p. 138. ISBN 978-0323287173. Archived from the original on 2016-08-20.
10. Grewal DS (2014). Atlas of Surgery of the Facial Nerve: An Otolaryngologist's Perspective. Jaypee Brothers Publishers. p. 46. ISBN 978-9350905807. Archived from the original on 2016-08-20.
11. ^ Morris AM, Deeks SL, Hill MD, Midroni G, Goldstein WC, Mazzulli T, et al. (2002). "Annualized incidence and spectrum of illness from an outbreak investigation of Bell's palsy". Neuroepidemiology. 21 (5): 255–61. doi:10.1159/000065645. PMID 12207155. S2CID 22771896. Archived from the original on 2009-07-13.
12. ^ Baugh RF, Basura GJ, Ishii LE, Schwartz SR, Drumheller CM, Burkholder R, et al. (November 2013). "Clinical practice guideline: Bell's Palsy executive summary". Otolaryngology–Head and Neck Surgery. 149 (5): 656–63. doi:10.1177/0194599813506835. PMID 24190889. S2CID 25468987.
13. Price T, Fife DG (January 2002). "Bilateral simultaneous facial nerve palsy". The Journal of Laryngology and Otology. 116 (1): 46–48. doi:10.1258/0022215021910113. PMID 11860653. S2CID 19276545.
14. Jain V, Deshmukh A, Gollomp S (July 2006). "Bilateral facial paralysis: case presentation and discussion of differential diagnosis". Journal of General Internal Medicine. 21 (7): C7–10. doi:10.1111/j.1525-1497.2006.00466.x. PMC 1924702. PMID 16808763.
15. ^ Mumenthaler M, Mattle H (2006). Fundamentals of Neurology. Germany: Thieme. pp. 197. ISBN 978-3131364517.
16. Moore KL, Dalley AF, Agur AM (2013). Clinically Oriented Anatomy. Lippincott Williams & Wilkins. ISBN 978-1451119459.
17. Facial Nerve Problems and Bell's Palsy Information on MedicineNet.com www.medicinenet.com Archived 2008-04-23 at the Wayback Machine
18. ^ Furuta Y, Ohtani F, Chida E, Mesuda Y, Fukuda S, Inuyama Y (May 2001). "Herpes simplex virus type 1 reactivation and antiviral therapy in patients with acute peripheral facial palsy". Auris, Nasus, Larynx. 28 Suppl (Suppl): S13–17. doi:10.1016/S0385-8146(00)00105-X. PMID 11683332.
19. "Bell's Palsy Fact Sheet | National Institute of Neurological Disorders and Stroke". www.ninds.nih.gov. Retrieved 2022-03-22.
20. ^ Kasse CA, Ferri RG, Vietler EY, Leonhardt FD, Testa JR, Cruz OL (October 2003). "Clinical data and prognosis in 1521 cases of Bell's palsy". International Congress Series. 1240: 641–47. doi:10.1016/S0531-5131(03)00757-X.
21. ^ Döner F, Kutluhan S (2000). "Familial idiopathic facial palsy". European Archives of Oto-Rhino-Laryngology. 257 (3): 117–19. doi:10.1007/s004050050205. PMID 10839481. S2CID 24403036. Archived from the original on 2013-01-06.
22. Silberstein SD, Silvestrini M (January 2015). "Does migraine produce facial palsy? For whom the Bell tolls". Neurology. 84 (2): 108–09. doi:10.1212/WNL.0000000000001136. hdl:11566/206361. PMID 25520314. S2CID 35589569.
23. Higgins-Dunn, Noah (2020-12-15). "FDA staff recommends watching for Bell's palsy in Moderna and Pfizer vaccine recipients". CNBC. Retrieved 2020-12-15.
24. Skuladottir, Astros Th (2021-02-18). "A meta-analysis uncovers the first sequence variant conferring risk of Bell's palsy". Scientific Reports. 11 (1): 4188. Bibcode:2021NatSR..11.4188S. doi:10.1038/s41598-021-82736-w. PMC 7893061. PMID 33602968.
25. MedlinePlus Medical Encyclopedia: Facial nerve palsy due to birth trauma Archived 2008-10-01 at the Wayback Machine retrieved 10 September 2008
26. Murakami S, Mizobuchi M, Nakashiro Y, Doi T, Hato N, Yanagihara N (January 1996). "Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle". Annals of Internal Medicine. 124 (1 Pt 1): 27–30. doi:10.7326/0003-4819-124-1_Part_1-199601010-00005. PMID 7503474. S2CID 22790049.
27. "S.C. TV Reporter Loses Her Smile after a Bell's Palsy Attack". Archived from the original on March 5, 2016.
28. ^ Garro A, Nigrovic LE (May 2018). "Managing Peripheral Facial Palsy". Annals of Emergency Medicine. 71 (5): 618–24. doi:10.1016/j.annemergmed.2017.08.039. PMID 29110887.
29. "Lyme Disease Data and surveillance (datasurveillance)". Lyme Disease. Centers for Disease Control and Prevention. Retrieved April 12, 2019.
30. "Lyme disease rashes and look-alikes (rashes)". Lyme Disease. Centers for Disease Control and Prevention. Retrieved April 18, 2019.
31. Wright WF, Riedel DJ, Talwani R, Gilliam BL (June 2012). "Diagnosis and management of Lyme disease". American Family Physician. 85 (11): 1086–93. PMID 22962880. Archived from the original on 27 September 2013.
32. Shapiro ED (May 2014). "Clinical practice. Lyme disease" (PDF). The New England Journal of Medicine. 370 (18): 1724–31. doi:10.1056/NEJMcp1314325. PMC 4487875. PMID 24785207. Archived from the original (PDF) on 19 October 2016.
33. Andrew E. Crouch; Marc H. Hohman; Claudio Andaloro (2022). Ramsay Hunt Syndrome. StatPearls. PMID 32491341.
34. ^ Hazin R, Azizzadeh B, Bhatti MT (November 2009). "Medical and surgical management of facial nerve palsy". Current Opinion in Ophthalmology. 20 (6): 440–50. doi:10.1097/ICU.0b013e3283313cbf. PMID 19696671. S2CID 45094564.
35. ^ Gronseth GS, Paduga R (November 2012). "Evidence-based guideline update: steroids and antivirals for Bell palsy: report of the Guideline Development Subcommittee of the American Academy of Neurology". Neurology. 79 (22): 2209–13. doi:10.1212/WNL.0b013e318275978c. PMID 23136264.
36. Gupta, Keshav Kumar; Balai, Edward; Tang, Ho Tsun; Ahmed, Abiya Amna; Doshi, Jayesh R. (2023-04-01). "Comparing the Use of High-Dose to Standard-Dose Corticosteroids for the Treatment of Bell's Palsy in Adults-A Systematic Review and Meta-analysis". Otology & Neurotology. 44 (4): 310–316. doi:10.1097/MAO.0000000000003823. ISSN 1537-4505. PMID 36706448. S2CID 256326046.
37. ^ Turgeon RD, Wilby KJ, Ensom MH (June 2015). "Antiviral treatment of Bell's palsy based on baseline severity: a systematic review and meta-analysis". The American Journal of Medicine. 128 (6): 617–28. doi:10.1016/j.amjmed.2014.11.033. PMID 25554380.
38. Sullivan FM, Swan IR, Donnan PT, Morrison JM, Smith BH, McKinstry B, et al. (October 2007). "Early treatment with prednisolone or acyclovir in Bell's palsy". The New England Journal of Medicine. 357 (16): 1598–607. doi:10.1056/NEJMoa072006. PMID 17942873. S2CID 3916563.
39. Stephenson M (October 4, 2012). "OTC Drops: Telling the Tears Apart". Review of Ophthalmology. Jobson Medical Information LLC. Retrieved April 16, 2019.
40. ^ National Institute of Neurological Disorders and Stroke (NINDS) (April 2003). "Bell's Palsy Fact Sheet". Archived from the original on 8 April 2011. Retrieved 2011-05-12.
41. Shafshak TS (March 2006). "The treatment of facial palsy from the point of view of physical and rehabilitation medicine". Europa Medicophysica. 42 (1): 41–47. PMID 16565685.
42. Teixeira LJ, Valbuza JS, Prado GF (December 2011). "Physical therapy for Bell's palsy (idiopathic facial paralysis)". The Cochrane Database of Systematic Reviews (12): CD006283. doi:10.1002/14651858.CD006283.pub3. PMID 22161401.
43. ^ Tiemstra JD, Khatkhate N (October 2007). "Bell's palsy: diagnosis and management". American Family Physician. 76 (7): 997–1002. PMID 17956069.
44. Menchetti, Isabella; McAllister, Kerrie; Walker, David; Donnan, Peter T. (January 26, 2021). "Surgical interventions for the early management of Bell's palsy". The Cochrane Database of Systematic Reviews. 1 (1): CD007468. doi:10.1002/14651858.CD007468.pub4. ISSN 1469-493X. PMC 8094225. PMID 33496980.
45. Chen N, Zhou M, He L, Zhou D, Li N (August 2010). He L (ed.). "Acupuncture for Bell's palsy". The Cochrane Database of Systematic Reviews. 2010 (8): CD002914. doi:10.1002/14651858.CD002914.pub5. PMC 7133542. PMID 20687071.
46. Holland NJ, Bernstein JM, Hamilton JW (February 2012). "Hyperbaric oxygen therapy for Bell's palsy". The Cochrane Database of Systematic Reviews. 2 (2): CD007288. doi:10.1002/14651858.CD007288.pub2. PMC 8406519. PMID 22336830.
47. Karnath B (14 February 2013). "Bell Palsy: Updated Guideline for Treatment". Consultant. HMP Communications. Archived from the original on February 25, 2013. Retrieved April 3, 2013.
48. Peitersen E (October 1982). "The natural history of Bell's palsy". The American Journal of Otology. 4 (2): 107–11. PMID 7148998. quoted in Roob G, Fazekas F, Hartung HP (January 1999). "Peripheral facial palsy: etiology, diagnosis and treatment". European Neurology. 41 (1): 3–9. doi:10.1159/000007990. PMID 9885321. S2CID 46877391. Archived from the original on 2009-07-13.
49. Peitersen E, Andersen P (June 1966). "Spontaneous course of 220 peripheral non-traumatic facial palsies". Acta Oto-Laryngologica. 63: 296–300. doi:10.3109/00016486709123595. PMID 6011525.
50. Yamamoto E, Nishimura H, Hirono Y (1988). "Occurrence of sequelae in Bell's palsy". Acta Oto-Laryngologica. Supplementum. 446: 93–96. doi:10.3109/00016488709121848. PMID 3166596.
51. ^ Ahmed A (May 2005). "When is facial paralysis Bell palsy? Current diagnosis and treatment". Cleveland Clinic Journal of Medicine. 72 (5): 398–401, 405. doi:10.3949/ccjm.72.5.398. PMID 15929453. S2CID 37815525.
52. Wolf SR (September 1998). "[Idiopathic facial paralysis]". Hno (in German). 46 (9): 786–98. doi:10.1007/s001060050314. PMID 9816532. S2CID 6740784. Archived from the original on 2000-06-23.
53. Morris, Andrew M.; Deeks, Shelley L.; Hill, Michael D.; Midroni, Gyl; Goldstein, Warren C.; Mazzulli, Tony; Davidson, Ross; Squires, Susan G.; Marrie, Thomas; McGeer, Allison; Low, Donald E. (September–October 2002). "Annualized Incidence and Spectrum of Illness from an Outbreak Investigation of Bell's Palsy". Neuroepidemiology. 21 (5): 256. doi:10.1159/000065645. PMID 12207155. S2CID 22771896.
54. Sajadi MM, Sajadi MR, Tabatabaie SM (July 2011). "The history of facial palsy and spasm: Hippocrates to Razi". Neurology. 77 (2): 174–78. doi:10.1212/WNL.0b013e3182242d23. PMC 3140075. PMID 21747074.
55. van de Graaf RC, Nicolai JP (November 2005). "Bell's palsy before Bell: Cornelis Stalpart van der Wiel's observation of Bell's palsy in 1683". Otology & Neurotology. 26 (6): 1235–38. doi:10.1097/01.mao.0000194892.33721.f0. PMID 16272948. S2CID 12630888.
56. Cantarella, Giovanna; Mazzola, Riccardo F. (2021-07-27). "The Bicentenary of Bell's Description of the Neuroanatomical Basis of Facial Paralysis: Historical Remarks". Otolaryngology–Head and Neck Surgery. 166 (5): 907–909. doi:10.1177/01945998211032172. PMID 34314273. S2CID 236473244.
57. "Jean Chretien: Veteran fighter". BBC. November 28, 2000. Retrieved November 7, 2020.

External links

• Ailments of unknown cause
• Facial nerve disorders
• Otorhinolaryngology